Neimeth International Pharmaceuticals Plc announced earnings results for the first quarter ended December 31, 2020. For the first quarter, the company announced sales was NGN 394.562 million compared to NGN 606.475 million a year ago. Operating loss was NGN 143.138 million compared to operating Income of NGN 111.678 million a year ago. Net loss was NGN 178.802 million compared to net income of NGN 82.652 million a year ago. Basic loss per share from continuing operations was NGN 0.09 compared to basic earnings per share from continuing operations of NGN 0.04 a year ago.